EECO Roadshow in China to Drive “EECiti,” and ComprehensiveMedical-Service Industry Upgrades

From April 19 – 25, 2026, Dr. Chula Sukmanop, Secretary-General of the Eastern Economic Corridor Office (EECO), along with his delegation, visited Guangzhou, Xiong’an, and Beijing in the People’s Republic of China. The mission aimed to conduct roadshow activities and negotiate collaborations with leading Chinese private sectors, focusing on driving the “EECiti” (Smart & Livable City) project while attracting investment in the Service and Medical Industries. The goal is to accelerate the formation of global partnerships to transform EECiti into
an international-standard Smart & Livable City.

A key highlight of this visit was the establishment of strategic cooperation for the development of the EECiti project. The EECO co-hosted the “EEC – Guangzhou Investment Promotion Roadshow” in Guangzhou with Mr. Kajtiti Wiwatwanont, Consul-General to Guangzhou. The event was attended by over 100 representatives from the public and private sectors in Guangzhou and surrounding areas, clearly reflecting the strong interest of Chinese investors in the potential of the EEC area and the EECiti project.

On this occasion, the EECO signed a Memorandum of Understanding (MOU) with Zhuhai Hengqin Jingtongrongzhi Technology Information Co., Ltd. to exchange information and conduct pre-feasibility studies for investment in the EECiti project. The cooperation focuses on Industrial and innovation development, Joint investment in clean energy infrastructure, energy storage systems, and Data Centers, and Comprehensive smart city development and construction.

Subsequently, in Xiong’an, the EECO held a business seminar titled “Business Opportunities in EEC,” attended by over 70 representatives from Chinese state-owned enterprises and the private sector. The office also signed an MOU with Ethaitat International (Hong Kong) Limited (ETIT) to establish a pre-strategic cooperation framework for EECiti development, covering eight key dimensions: investment promotion, integrated urban development, smart city infrastructure, core infrastructure systems, diversified financial system development, annual operation planning, investment and financing structures, and the selection framework for a Master Developer.

The EECO also held discussions with leading Chinese organizations and companies specializing in infrastructure and smart city development to adapt best practices for EECiti. These included:

• China Academy of Urban Planning and Design (CAUPD): China’s primary national urban planning agency.
• Guangzhou Development New Energy Group Incorporated: Experts in clean energy and Smart Grid systems.
• Pearl River Enterprise Group (PREG): A developer of large-scale urban renewal projects.
• Qingdao Hainayun Intelligent System: A software developer for energy management systems.

The expertise gained from these partners will be one component of enhancing the design and management of EECiti, ensuring it becomes a smart city that supports both investment and high-quality living for all.

Parallel to urban development, the EECO focused on creating deep collaborations across the entire medical industry supply chain (Upstream, Midstream, and Downstream) to elevate the “Medical Ecosystem” of the EEC. This initiative extends beyond EECiti to cover the entire healthcare system, including pharmaceuticals, biopharmaceuticals, medical device manufacturing, advanced medical services, and Medical & Wellness Tourism.

• Upstream: The delegation consulted with Xiamen Telun Pharmaceutical, a GMP-certified pharmaceutical manufacturer focusing on integrating health industries with biopharmaceuticals and medicines derived from raw materials that serve both food and herbs.
• Advanced Medical Technology: The team met with Reforgene Medicine, a company specializing in the research, development, and production of Gene Therapy products under the “Genetically Towards the Region” concept. Their focus is on treating specialized genetic diseases such as Thalassemia (both Alpha and Beta), cardiovascular diseases, and Hepatitis B (HBV).
• Midstream & Downstream: Discussions were held with Zhong Hong Medical, a company specializing in the R&D and distribution of medical devices and SaMD (Software as a Medical Device), such as patient temperature control systems, real-time patient monitoring systems, and single-use medical devices ranging from general to medical-grade standards.

This visit to China reflects the confidence and growing interest of investors in the potential of the EEC and its target industries. The collaborations with Chinese firms serve as a starting point for feasibility studies and investment opportunities for the EECiti project. These partnerships are expected to support the development of EECiti as a smart and livable city, catering to future investment, residency, and quality of life.